LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.

    Hsu, Caroline M / Weiner, Daniel E / Aweh, Gideon / Miskulin, Dana C / Manley, Harold J / Stewart, Carol / Ladik, Vlad / Hosford, John / Lacson, Edward C / Johnson, Douglas S / Lacson, Eduardo

    American journal of kidney diseases : the official journal of the National Kidney Foundation

    2021  Volume 77, Issue 5, Page(s) 748–756.e1

    Abstract: ... characteristics associated with COVID-19 and risk factors associated with mortality among patients following COVID ... Of the 438 maintenance dialysis patients with COVID-19, 109 (24.9%) died. Older age, heart disease, and ... participants: Maintenance dialysis patients in clinics of a midsize national dialysis provider that had ...

    Abstract Rationale & objective: During the coronavirus disease 2019 (COVID-19) pandemic, patients receiving maintenance dialysis are a highly vulnerable population due to their comorbidities and circumstances that limit physical distancing during treatment. This study sought to characterize the risk factors for and outcomes following COVID-19 in this population.
    Study design: Retrospective cohort study.
    Setting & participants: Maintenance dialysis patients in clinics of a midsize national dialysis provider that had at least 1 patient who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from February to June 2020.
    Predictors: Demographics, dialysis characteristics, residence in a congregated setting, comorbid conditions, measurements of frailty, and use of selected medications.
    Outcomes: COVID-19, defined as having a positive SARS-CoV-2 test result, and all-cause mortality among those with COVID-19.
    Analytical approach: Logistic regression analyses conducted to identify clinical characteristics associated with COVID-19 and risk factors associated with mortality among patients following COVID-19.
    Results: 438 of 7948 (5.5%) maintenance dialysis patients developed COVID-19. Male sex, Black race, in-center dialysis (vs home dialysis), treatment at an urban clinic, residence in a congregate setting, and greater comorbidity were associated with contracting COVID-19. Odds of COVID-19 were 17-fold higher for those residing in a congregated setting (odds ratio [OR], 17.10 [95% CI, 13.51-21.54]). Of the 438 maintenance dialysis patients with COVID-19, 109 (24.9%) died. Older age, heart disease, and markers of frailty were associated with mortality.
    Limitations: No distinction was detected between symptomatic and asymptomatic SARS-CoV-2 positivity, with asymptomatic screening limited by testing capacity during this initial COVID-19 surge period.
    Conclusions: COVID-19 is common among patients receiving maintenance dialysis, particularly those residing in congregate settings. Among maintenance dialysis patients with COVID-19, mortality is high, exceeding 20%.
    MeSH term(s) Age Factors ; Aged ; COVID-19/mortality ; COVID-19/therapy ; Comorbidity ; Female ; Frailty/diagnosis ; Frailty/epidemiology ; Frailty/etiology ; Heart Diseases/epidemiology ; Humans ; Infection Control/methods ; Kidney Failure, Chronic/epidemiology ; Kidney Failure, Chronic/therapy ; Male ; Middle Aged ; Mortality ; Nursing Homes/statistics & numerical data ; Renal Dialysis/methods ; Renal Dialysis/statistics & numerical data ; Retrospective Studies ; Risk Assessment ; Risk Factors ; SARS-CoV-2/isolation & purification ; United States/epidemiology
    Language English
    Publishing date 2021-01-17
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604539-x
    ISSN 1523-6838 ; 0272-6386
    ISSN (online) 1523-6838
    ISSN 0272-6386
    DOI 10.1053/j.ajkd.2021.01.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Epidemiology of COVID-19 in Tehran, Iran

    Hamidreza Hatamabadi / Tahereh Sabaghian / Amir Sadeghi / Kamran Heidari / Seyed Amir Ahmad Safavi-Naini / Mehdi Azizmohammad Looha / Nazanin Taraghikhah / Shayesteh Khalili / Keivan Karrabi / Afsaneh Saffarian / Saba Shahsavan / Hossein Majlesi / Amirreza Allahgholipour Komleh / Saba Hatari / Nadia Zameni / Saba Ilkhani / Shideh Moftakhari Hajimirzaei / Aydin Ghaffari / Mohammad Mahdi Fallah /
    Reyhaneh Kalantar / Nariman Naderi / Parnian Bahmaei / Naghmeh Asadimanesh / Romina Esbati / Omid Yazdani / Fatemeh Shojaeian / Zahra Azizan / Nastaran Ebrahimi / Fateme Jafarzade / Amirali Soheili / Fatemeh Gholampoor / Negarsadat Namazi / Ali Solhpour / Tannaz Jamialahamdi / Mohamad Amin Pourhoseingholi / Amirhossein Sahebkar

    BioMed Research International, Vol

    A Cohort Study of Clinical Profile, Risk Factors, and Outcomes

    2022  Volume 2022

    Abstract: ... healthcare providers in stratifying patients, based on their risk factors and healthcare requirements to improve ... clinical profile, outcomes of disease, and finding the predictors of death due to COVID-19. Results ... in Tehran, Iran. All patients were admitted based on the WHO, CDC, and Iran’s National Guidelines ...

    Abstract Background. The outbreak of coronavirus disease 2019 (COVID-19) dates back to December 2019 in China. Iran has been among the most prone countries to the virus. The aim of this study was to report demographics, clinical data, and their association with death and CFR. Methods. This observational cohort study was performed from 20th March 2020 to 18th March 2021 in three tertiary educational hospitals in Tehran, Iran. All patients were admitted based on the WHO, CDC, and Iran’s National Guidelines. Their information was recorded in their medical files. Multivariable analysis was performed to assess demographics, clinical profile, outcomes of disease, and finding the predictors of death due to COVID-19. Results. Of all 5318 participants, the median age was 60.0 years, and 57.2% of patients were male. The most significant comorbidities were hypertension and diabetes mellitus. Cough, dyspnea, and fever were the most dominant symptoms. Results showed that ICU admission, elderly age, decreased consciousness, low BMI, HTN, IHD, CVA, dialysis, intubation, Alzheimer disease, blood injection, injection of platelets or FFP, and high number of comorbidities were associated with a higher risk of death related to COVID-19. The trend of CFR was increasing (WPC: 1.86) during weeks 25 to 51. Conclusions. Accurate detection of predictors of poor outcomes helps healthcare providers in stratifying patients, based on their risk factors and healthcare requirements to improve their survival chance.
    Keywords Medicine ; R
    Subject code 610
    Language English
    Publishing date 2022-01-01T00:00:00Z
    Publisher Hindawi Limited
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: COVID-19 and chronic kidney disease: a comprehensive review.

    Pecly, Inah Maria D / Azevedo, Rafael B / Muxfeldt, Elizabeth S / Botelho, Bruna G / Albuquerque, Gabriela G / Diniz, Pedro Henrique P / Silva, Rodrigo / Rodrigues, Cibele I S

    Jornal brasileiro de nefrologia

    2021  Volume 43, Issue 3, Page(s) 383–399

    Abstract: ... an important risk factor for disease severity and higher in-hospital mortality amongst patients with COVID-19 ... of safety measures to reduce transmission risk and optimize dialysis treatment during the COVID-19 pandemic. Current ... Thus, we provide a comprehensive review of the clinical outcomes and prognosis of patients with CKD under ...

    Abstract Kidney impairment in hospitalized patients with SARS-CoV-2 infection is associated with increased in-hospital mortality and worse clinical evolution, raising concerns towards patients with chronic kidney disease (CKD). From a pathophysiological perspective, COVID-19 is characterized by an overproduction of inflammatory cytokines (IL-6, TNF-alpha), causing systemic inflammation and hypercoagulability, and multiple organ dysfunction syndrome. Emerging data postulate that CKD under conservative treatment or renal replacement therapy (RRT) is an important risk factor for disease severity and higher in-hospital mortality amongst patients with COVID-19. Regarding RAAS blockers therapy during the pandemic, the initial assumption of a potential increase and deleterious impact in infectivity, disease severity, and mortality was not evidenced in medical literature. Moreover, the challenge of implementing social distancing in patients requiring dialysis during the pandemic prompted national and international societies to publish recommendations regarding the adoption of safety measures to reduce transmission risk and optimize dialysis treatment during the COVID-19 pandemic. Current data convey that kidney transplant recipients are more vulnerable to more severe infection. Thus, we provide a comprehensive review of the clinical outcomes and prognosis of patients with CKD under conservative treatment and dialysis, and kidney transplant recipients and COVID-19 infection.
    MeSH term(s) COVID-19 ; Humans ; Pandemics ; Renal Dialysis ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/epidemiology ; Renal Insufficiency, Chronic/therapy ; SARS-CoV-2
    Language Portuguese
    Publishing date 2021-05-13
    Publishing country Brazil
    Document type Journal Article ; Review
    ZDB-ID 2057873-8
    ISSN 2175-8239 ; 2175-8239
    ISSN (online) 2175-8239
    ISSN 2175-8239
    DOI 10.1590/2175-8239-JBN-2020-0203
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19.

    Menez, Steven / Moledina, Dennis G / Thiessen-Philbrook, Heather / Wilson, F Perry / Obeid, Wassim / Simonov, Michael / Yamamoto, Yu / Corona-Villalobos, Celia P / Chang, Crystal / Garibaldi, Brian T / Clarke, William / Farhadian, Shelli / Dela Cruz, Charles / Coca, Steven G / Parikh, Chirag R

    American journal of kidney diseases : the official journal of the National Kidney Foundation

    2021  Volume 79, Issue 2, Page(s) 257–267.e1

    Abstract: ... Patients hospitalized with COVID-19 (n=153) at 2 academic medical centers between April and June 2020 ... kidney outcomes in other settings and may provide additional prognostic information in patients ... 2019 (COVID-19) and associated with poor outcomes. Urinary biomarkers have been associated with adverse ...

    Abstract Rationale & objective: Acute kidney injury (AKI) is common in patients with coronavirus disease 2019 (COVID-19) and associated with poor outcomes. Urinary biomarkers have been associated with adverse kidney outcomes in other settings and may provide additional prognostic information in patients with COVID-19. We investigated the association between urinary biomarkers and adverse kidney outcomes among patients hospitalized with COVID-19.
    Study design: Prospective cohort study.
    Setting & participants: Patients hospitalized with COVID-19 (n=153) at 2 academic medical centers between April and June 2020.
    Exposure: 19 urinary biomarkers of injury, inflammation, and repair.
    Outcome: Composite of KDIGO (Kidney Disease: Improving Global Outcomes) stage 3 AKI, requirement for dialysis, or death within 60 days of hospital admission. We also compared various kidney biomarker levels in the setting of COVID-19 versus other common AKI settings.
    Analytical approach: Time-varying Cox proportional hazards regression to associate biomarker level with composite outcome.
    Results: Out of 153 patients, 24 (15.7%) experienced the primary outcome. Twofold higher levels of neutrophil gelatinase-associated lipocalin (NGAL) (HR, 1.34 [95% CI, 1.14-1.57]), monocyte chemoattractant protein (MCP-1) (HR, 1.42 [95% CI, 1.09-1.84]), and kidney injury molecule 1 (KIM-1) (HR, 2.03 [95% CI, 1.38-2.99]) were associated with highest risk of sustaining primary composite outcome. Higher epidermal growth factor (EGF) levels were associated with a lower risk of the primary outcome (HR, 0.61 [95% CI, 0.47-0.79]). Individual biomarkers provided moderate discrimination and biomarker combinations improved discrimination for the primary outcome. The degree of kidney injury by biomarker level in COVID-19 was comparable to other settings of clinical AKI. There was evidence of subclinical AKI in COVID-19 patients based on elevated injury biomarker level in patients without clinical AKI defined by serum creatinine.
    Limitations: Small sample size with low number of composite outcome events.
    Conclusions: Urinary biomarkers are associated with adverse kidney outcomes in patients hospitalized with COVID-19 and may provide valuable information to monitor kidney disease progression and recovery.
    MeSH term(s) Acute Kidney Injury/diagnosis ; Acute Kidney Injury/epidemiology ; Biomarkers ; COVID-19 ; Creatinine ; Humans ; Lipocalin-2 ; Prognosis ; Prospective Studies ; SARS-CoV-2
    Chemical Substances Biomarkers ; Lipocalin-2 ; Creatinine (AYI8EX34EU)
    Language English
    Publishing date 2021-10-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 604539-x
    ISSN 1523-6838 ; 0272-6386
    ISSN (online) 1523-6838
    ISSN 0272-6386
    DOI 10.1053/j.ajkd.2021.09.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Epidemiology of COVID-19 in Tehran, Iran: A Cohort Study of Clinical Profile, Risk Factors, and Outcomes.

    Hatamabadi, Hamidreza / Sabaghian, Tahereh / Sadeghi, Amir / Heidari, Kamran / Safavi-Naini, Seyed Amir Ahmad / Looha, Mehdi Azizmohammad / Taraghikhah, Nazanin / Khalili, Shayesteh / Karrabi, Keivan / Saffarian, Afsaneh / Shahsavan, Saba / Majlesi, Hossein / Allahgholipour Komleh, Amirreza / Hatari, Saba / Zameni, Nadia / Ilkhani, Saba / Hajimirzaei, Shideh Moftakhari / Ghaffari, Aydin / Fallah, Mohammad Mahdi /
    Kalantar, Reyhaneh / Naderi, Nariman / Bahmaei, Parnian / Asadimanesh, Naghmeh / Esbati, Romina / Yazdani, Omid / Shojaeian, Fatemeh / Azizan, Zahra / Ebrahimi, Nastaran / Jafarzade, Fateme / Soheili, Amirali / Gholampoor, Fatemeh / Namazi, Negarsadat / Solhpour, Ali / Jamialahamdi, Tannaz / Pourhoseingholi, Mohamad Amin / Sahebkar, Amirhossein

    BioMed research international

    2022  Volume 2022, Page(s) 2350063

    Abstract: ... helps healthcare providers in stratifying patients, based on their risk factors and healthcare ... clinical profile, outcomes of disease, and finding the predictors of death due to COVID-19.: Results ... in Tehran, Iran. All patients were admitted based on the WHO, CDC, and Iran's National Guidelines ...

    Abstract Background: The outbreak of coronavirus disease 2019 (COVID-19) dates back to December 2019 in China. Iran has been among the most prone countries to the virus. The aim of this study was to report demographics, clinical data, and their association with death and CFR.
    Methods: This observational cohort study was performed from 20th March 2020 to 18th March 2021 in three tertiary educational hospitals in Tehran, Iran. All patients were admitted based on the WHO, CDC, and Iran's National Guidelines. Their information was recorded in their medical files. Multivariable analysis was performed to assess demographics, clinical profile, outcomes of disease, and finding the predictors of death due to COVID-19.
    Results: Of all 5318 participants, the median age was 60.0 years, and 57.2% of patients were male. The most significant comorbidities were hypertension and diabetes mellitus. Cough, dyspnea, and fever were the most dominant symptoms. Results showed that ICU admission, elderly age, decreased consciousness, low BMI, HTN, IHD, CVA, dialysis, intubation, Alzheimer disease, blood injection, injection of platelets or FFP, and high number of comorbidities were associated with a higher risk of death related to COVID-19. The trend of CFR was increasing (WPC: 1.86) during weeks 25 to 51.
    Conclusions: Accurate detection of predictors of poor outcomes helps healthcare providers in stratifying patients, based on their risk factors and healthcare requirements to improve their survival chance.
    MeSH term(s) Aged ; COVID-19/epidemiology ; Cohort Studies ; Comorbidity ; Female ; Humans ; Hypertension/epidemiology ; Iran/epidemiology ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; SARS-CoV-2
    Language English
    Publishing date 2022-05-10
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 2698540-8
    ISSN 2314-6141 ; 2314-6133
    ISSN (online) 2314-6141
    ISSN 2314-6133
    DOI 10.1155/2022/2350063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Characteristics and outcomes of 7620 Multiple Sclerosis patients admitted with COVID-19 in the United States

    Ramphul, Kamleshun / Sombans, Shaheen / Verma, Renuka / Lohana, Petras / Dhillon, Balkiranjit Kaur / Mejias, Stephanie Gonzalez / Sanikommu, Sailaja / Ramphul, Yogeshwaree / Pekyi-Boateng, Prince Kwabla

    medRxiv

    Abstract: ... the 2020 National Inpatient Sample (NIS). Characteristics of COVID-19 patients with and without MS were ... Finally, we investigated the risk factors of various outcomes among MS patients. Results We identified 1 ... Whites, and 63.3% were covered by Medicare. Compared to non-MS patients, MS patients with COVID-19 were ...

    Abstract Background At the start of the COVID-19 pandemic, several experts raised concerns about its impact on Multiple Sclerosis (MS) patients. Several small sample studies were published throughout the pandemic highlighting certain risk factors and outcomes. This study aims to provide a perspective using the biggest inpatient database from the United States. Method We screened for COVID-19 cases between April to December 2020, via the 2020 National Inpatient Sample (NIS). Characteristics of COVID-19 patients with and without MS were studied. The odds of mortality, mechanical ventilation and non-invasive ventilation were also analyzed. Finally, we investigated the risk factors of various outcomes among MS patients. Results We identified 1,628,110 hospitalizations with COVID-19, including 7620 (0.5%) MS patients. 68.6% of MS cases were Whites, and 63.3% were covered by Medicare. Compared to non-MS patients, MS patients with COVID-19 were mostly Females, had depression, peripheral vascular disease, and smoked. However, MS patients had lower cases of alcohol abuse, obesity, hyperlipidemia, diabetes, hypertension, CKD, or maintenance dialysis. MS patients with COVID-19 were also younger (mean age 60.65 years vs. 62.60 years, p<0.01). 8.9% of MS patients with COVID-19 did not survive their hospitalization, and it was lower than non-MS cases (12.9%, aOR 0.783, 95% CI 0.721-0.852, p<0.01). Less MS patients with COVID-19 needed non-invasive ventilation (4.5% vs. 6.4%, aOR 0.790, 95% CI 0.706-0.883, p<0.01) and mechanical ventilation (9.0% vs. 11.2%, aOR 1.017, 95% CI 0.937-1.104, p=0.687). Furthermore, MS patients with COVID-19 reported higher odds of non-invasive ventilation if they were of ages 60 and above (aOR 2.124, p<0.01), had chronic pulmonary disease (aOR 1.691, p<0.01), obesity (aOR 1.69, p<0.01), and diabetes (aOR 1.573, p<0.01). Private insurance beneficiaries showed reduced risk compared to Medicare (aOR 0.523, p<0.01). Similarly, for mechanical ventilation, those ages 60 and above (aOR 1.404, p<0.01), alcohol abuse (aOR 6.404, p<0.01), obesity (aOR 1.417, p<0.01), diabetes (aOR 1.992, p<0.01), hypertension (aOR 1.269, p=0.016), or dialysis (aOR 3.003, p<0.01) had higher odds, while females (aOR 0.700, p<0.01), smokers (aOR 0.588, p<0.01), and those with depression (aOR 0.698, p<0.01) or hyperlipidemia (aOR 0.711, p<0.01) showed reduced odds. Our study further found higher odds of mortality among those of age 60 and above (aOR 3.813, p<0.01), chronic pulmonary disease (aOR 1.739, p<0.01), obesity (aOR 1.425, p<0.01), CKD (aOR 1.982, p<0.01), or a history of old MI (aOR 1.864, p<0.01) while females (aOR 0.610, p<0.01), smokers (aOR 0.770, p<0.01), as well as those with depression (aOR 0.695, p<0.01), and hyperlipidemia (aOR 0.769, p<0.01) showed better outcomes. Blacks had lower odds of dying (aOR 0.636, p<0.01), whereas Hispanics had higher odds of dying (aOR 1.674, p<0.01), compared to Whites. Medicaid and Privately insured patients had lower odds of dying compared to Medicare i.e. (aOR 0.435, p<0.01), and (aOR 0.488, p<0.01), respectively. Conclusion We found several differences in patient characteristics among MS and non-MS patients with COVID-19. MS patients were also less likely to die or require non-invasive ventilation than non-MS patients. Further risk factors influencing the different outcomes among MS patients were also identified.
    Keywords covid19
    Language English
    Publishing date 2023-02-16
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2023.02.15.23285994
    Database COVID19

    Kategorien

To top